Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Ryanair Holdings PLC (RYAAY) - free report >>
AutoNation, Inc. (AN) - free report >>
easyjet PLC (EJTTF) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Ryanair Holdings PLC (RYAAY) - free report >>
AutoNation, Inc. (AN) - free report >>
easyjet PLC (EJTTF) - free report >>
Image: Bigstock
New Strong Sell Stocks for April 18th
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
AutoNation, Inc. (AN - Free Report) is an automotive retailer. The Zacks Consensus Estimate for its current year earnings has been revised 0.7% downward over the last 30 days.
easyJet plc (EJTTF - Free Report) operates as an airline carrier. The Zacks Consensus Estimate for its current year earnings has been revised 27.5% downward over the last 30 days.
Japan Tobacco Inc. JAPAY manufactures cigarettes and other tobacco products. The Zacks Consensus Estimate for its current year earnings has been revised 5.3% downward over the last 30 days.
Ryanair Holdings plc (RYAAY - Free Report) is a provider of scheduled-passenger airline services. The Zacks Consensus Estimate for its current year earnings has been revised 1.9% downward over the last 30 days.
Sartorius Aktiengesellschaft (SARTF - Free Report) is a pharmaceutical and laboratory equipment supplier. The Zacks Consensus Estimate for its current year earnings has been revised 1.2% downward over the last 30 days.
View the entire Zacks Rank #5 List.